Fulgent Genetics (FLGT) Change in Account Payables (2015 - 2026)

Fulgent Genetics has disclosed Change in Account Payables across 12 years of filings, most recently posting -$3.4 million for Q2 2026.

• In Q2 2026, Change in Account Payables fell 984.72% year-over-year to -$3.4 million; the TTM figure through Jun 2026 stood at -$3.0 million (down 350.5% YoY), while the FY2025 annual figure was $550000.0, down 82.06% from the prior year.
• Change in Account Payables came in at -$3.4 million for Q2 2026 at Fulgent Genetics, down from -$408000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $7.0 million in Q4 2022 to a low of -$22.1 million in Q3 2022.
• Average Change in Account Payables over 5 years is -$1.8 million, with a median of -$326500.0 recorded in 2024.
• The largest YoY upside for Change in Account Payables was 318.23% in 2022 against a maximum downside of 1860.21% in 2022.
• Over 5 years, Change in Account Payables stood at $7.0 million in 2022, then slumped by 98.16% to $129000.0 in 2023, then plunged by 726.36% to -$808000.0 in 2024, then jumped by 214.36% to $924000.0 in 2025, then tumbled by 469.59% to -$3.4 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were -$3.4 million in Q2 2026, -$408000.0 in Q1 2026, and $924000.0 in Q4 2025.